USE OF DRUGS ARTHRA MSM FORTE AND ARTHRA FOR OSTEOARTHRITIS AND BACK PAINS
https://doi.org/10.21518/2079-701X-2017-10-96-101
Abstract
Pain is the most common symptom that causes the patient to contact a doctor, and the lower back and joints are the major places where it occurs. To date treatment of OA and lower back pain (LBP) is focused primarily on the symptoms of disease, that is, reducing pain syndrome and improving the functional state of joints and spine. The use of NSAIDs can quickly reduce the intensity of pain and accelerate the recovery of the motor activity in OA and LBP. However, the use of this group of drugs is related to the development of undesirable events on the part of the gastrointestinal tract, cardiovascular system, kidneys and other organs, which is particularly important in the comorbid conditions of the elderly patients. This makes it clear that there is a high level of interest in the slow-symptomatic drug group that approved themselves in the arthrologic practice. This group includes glucosamine (GA), chondroitin sulphate (CS), which have the highest evidentiary basis by efficiency. Numerous clinical studies have shown that CS and GA have anti-inflammatory characteristics contributing to reducing pain syndrome and can be useful in treating OA and LBP.
About the Authors
L. I. Alekseeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
MD, Prof.
Moscow
E. P. Sharapova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
PhD in medicine.
Moscow
References
1. Насонов Е.Л. Болевой синдром при патологии опорно-двигательного аппарата. Врач, 2002, 4: 15-9.
2. Эрдес Ш.Ф., Фоломеева О.М. Ревматические заболевания и инвалидность взрослого населения Российской Федерации. Научнопрактическая ревматология, 2007, 4: 4-10.
3. Галушко Е.А. Медико-социальная значимость ревматических заболеваний. Автореф. дис. ... д-ра мед. наук. М., 2011.
4. Hoy D et al. Low Back Pain Prevalent in Different Parts of the World. Ann Rheum Dis. Published online January 30 and March 24, 2014.
5. Chou R et al. Ann Intern Med, 2007, 147: 478-91
6. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for thenon-surgical management of knee osteoarthritis. Osteoarthritis Cartilage, 2014, 22(3): 363-88.
7. Roelofs P, Deyo R, Koes B, Scholten R van Tulder M. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev, 2008, 23(1): CD000396.
8. Henrotin Y, Marty M, Mobasheri A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas, 2014, 78: 184-187.
9. Fransen M, Agaliotis M, Nair L et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis, 2014, 0: 1-8. doi:10.1136/annrheumdis-2013-203954.
10. Clegg DO et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med, 2006, 354: 795-808.
11. Jomphe C, Gabriac M, Hale TM et al. Chondroitin Sulfate Inhibits the Nuclear Translocation of Nuclear Factor-κB in Interleukin-1β-Stimulated Chondrocytes. Basic & Clinical Pharmacology & Toxicology, 2007, 102: 59-65.
12. Martel-Pelletier J et al. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Ann Rheum Dis, 2013, 203906. doi: 10.1136/annrheumdis-2013-203906.
13. Hochbergy MC, et al. The Multicentric Osteoarthritis inter VEntion Study with Sysadoa (MOVES). MOVES Steering Committee. Osteoarthritis and Cartilage, 2014, 22: 7-56.
14. Алексеева Л.И., Чичасова Н.В., Мендель О.И. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата АРТРА® в России. РМЖ, 2005, 13, 24(248): 1637-1640.
15. Kocsis JJ, Harkaway S, Snyder R. Biological effects of the metabolites of dimethyl sulfoxide. Ann N Y Acad Sci, 1975, 243: 104-109.
16. Murav’ev IuV, Venikova MS, Pleskovskaia GN, et al. Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis. Patol Fiziol Eksp Ter, 1991, 2: 37-9.
17. Engelke UF, Tangerman A, Willemsen MA, Moskau D, Loss S, Mudd SH, Wevers RA. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by onedimensional (1)H and two-dimensional (1)H-(13)C NMR. NMR Biomed, 2005, 18: 331-336.
18. Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res, 2003, 23: 453-458.
19. Alam SS, Layman DL. Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells. Ann N Y Acad Sci, 1983, 411: 318-320.
20. Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med, 1987, 110: 91-96.
21. Usha P, Naidu M. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Invest, 2004, 24: 353-363.
22. Pagonis TA, Givissis PK, Kritis AC, Christodoulou AC. The Effect of Methylsulfonylmethane on Osteoarthritic Large Joints and Mobility. International Journal of Orthopaedics, 2014, 1(1): 19-24.
23. Sudha Vidyasagar, Prabhu Mukhyaprana, U Shashikiran, Adiga Sachidananda, Sharath RAO, K Laxminarayana Bairy, Shalini Adiga and B Jayaprakash. Efficacy and Tolerability of Glucosamine Chondroitin Sulphate – Methyl Sulfonyl Methane (MSM) in Osteoarthritis of Knee in Indian Patients. IJPT, 2004, 3: 61-65.
24. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. OsteoArthritis and Cartilage, 2006, 14: 286-294.
25. Алексеева Л., Алексеев В., Баринов А., Синх Г. Новые подходы к лечению неспецифических болей в нижней части спины. Научно-практическая ревматология, 2016, 54(1): 16-20.
26. Алексеева Л.И., Шарапова Е.П. Лечение хронической боли в суставах и спине комбинированными препаратами хондроитин сульфатом и глюкозамин гидрохлоридом. Consilium Meedicum, 2016, 18(2): 62-67.
27. Алексеева Л.И., Шарапова Е.П., Кашеварова Н.Г., Таскина Е.А., Аникин С.Г., Короткова Т.А., Пьяных С.Е. Применение АРТРА MСM ФОРТЕ у пациентов с остеоартрозом коленного сустава: результаты рандомизированного открытого сравнительного изучения эффективности и переносимости препарата. Терапевтический архив, 2015, 87, 12: 49-54.
Review
For citations:
Alekseeva LI, Sharapova EP. USE OF DRUGS ARTHRA MSM FORTE AND ARTHRA FOR OSTEOARTHRITIS AND BACK PAINS. Meditsinskiy sovet = Medical Council. 2017;(10):96-101. (In Russ.) https://doi.org/10.21518/2079-701X-2017-10-96-101
Views:
1251
Email this article 